abstract |
The invention provides novel kinase inhibitors that are useful as therapeutic agents for example in the treatment malignancies where the compounds have the general formula I wherein A, X, Y, Z, Ra, Rb, Rc, R<SUB>1</SUB>, R<SUB>2</SUB>, R<SUB>3 </SUB>and m are defined herein. |